ATE430584T1 - Systeme und verfahren zur topischen behandlung mit stickstoffmonoxyd - Google Patents

Systeme und verfahren zur topischen behandlung mit stickstoffmonoxyd

Info

Publication number
ATE430584T1
ATE430584T1 AT00932745T AT00932745T ATE430584T1 AT E430584 T1 ATE430584 T1 AT E430584T1 AT 00932745 T AT00932745 T AT 00932745T AT 00932745 T AT00932745 T AT 00932745T AT E430584 T1 ATE430584 T1 AT E430584T1
Authority
AT
Austria
Prior art keywords
gel
hydroxyethylcellulose
burns
intra
gels
Prior art date
Application number
AT00932745T
Other languages
English (en)
Inventor
William Seitz
Robert Garfield
Alexandru Balaban
Randall Stewart
Original Assignee
Nitric Oxide Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22250448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE430584(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nitric Oxide Solutions filed Critical Nitric Oxide Solutions
Application granted granted Critical
Publication of ATE430584T1 publication Critical patent/ATE430584T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
AT00932745T 1998-06-10 2000-05-24 Systeme und verfahren zur topischen behandlung mit stickstoffmonoxyd ATE430584T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/095,174 US6103275A (en) 1998-06-10 1998-06-10 Systems and methods for topical treatment with nitric oxide
PCT/US2000/014239 WO2001089572A1 (en) 1998-06-10 2000-05-24 Systems and methods for topical treatment with nitric oxide

Publications (1)

Publication Number Publication Date
ATE430584T1 true ATE430584T1 (de) 2009-05-15

Family

ID=22250448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00932745T ATE430584T1 (de) 1998-06-10 2000-05-24 Systeme und verfahren zur topischen behandlung mit stickstoffmonoxyd

Country Status (7)

Country Link
US (2) US6103275A (de)
EP (1) EP1283724B1 (de)
AT (1) ATE430584T1 (de)
AU (2) AU5042600A (de)
CA (1) CA2410990C (de)
DE (1) DE60042174D1 (de)
WO (1) WO2001089572A1 (de)

Families Citing this family (214)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
GB9905425D0 (en) * 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
US20050142218A1 (en) * 2000-03-09 2005-06-30 Queen Mary & Westfield College Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia
DE19945484A1 (de) * 1999-09-22 2001-04-05 Kolb Bachofen Victoria NO-freisetzende topisch applizierbare Zusammensetzung
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US7678391B2 (en) * 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
WO2001080890A2 (en) 2000-04-26 2001-11-01 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US20050142217A1 (en) * 2000-04-26 2005-06-30 Adams Michael A. Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
GB0021317D0 (en) * 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
SE0004026D0 (sv) * 2000-11-03 2000-11-03 Peter Wiklund New use
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US6706274B2 (en) 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
GB0119011D0 (en) * 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
US8066904B2 (en) * 2001-09-05 2011-11-29 Geno Llc Controlled generation of nitric oxide
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
DE60306134T2 (de) * 2002-04-24 2007-04-19 Insense Ltd., Sharnbrook Wundauflage enthaltend ein oxidoreduktase-enzym in hydratiertem zustand
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
GB0224986D0 (en) * 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US9138707B2 (en) 2002-12-10 2015-09-22 Sy Kimball Portable, nitric oxide generator
CA2413834A1 (en) 2002-12-10 2004-06-10 1017975 Alberta Limited Nitric oxide gas generator
FR2850579B1 (fr) * 2003-02-03 2006-08-18 Oreal Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
FR2850578B1 (fr) * 2003-02-03 2006-07-28 Oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
CA2456035A1 (fr) * 2003-02-03 2004-08-03 L'oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
AU2004233347A1 (en) * 2003-04-23 2004-11-04 Darrell H. Reneker Sequestered reactive materials
GB0313217D0 (en) 2003-06-09 2003-07-16 Insense Ltd Improvements in or relating to skin dressings
US20050181026A1 (en) * 2003-06-09 2005-08-18 Insense Limited Skin dressings
ES2645566T3 (es) * 2003-07-03 2017-12-05 The University Court Of The University Of St Andrews Zeolitas para el suministro de óxido nítrico
JP5564157B2 (ja) * 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 心臓血管状態の処置のための亜硝酸塩の使用方法
US20090136410A1 (en) * 2003-07-25 2009-05-28 Smith Daniel J Stabilization and ionic triggering of nitric oxide release
GB0322342D0 (en) * 2003-09-23 2003-10-22 Gamble Reed Skin patch
US11298453B2 (en) 2003-10-28 2022-04-12 Smith & Nephew Plc Apparatus and method for wound cleansing with actives
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
EP1813290A1 (de) * 2004-01-30 2007-08-01 Insense Limited Hautverbänden mit hydratisierten hydrogelen, Lactationen und Glucose
CA2556967A1 (en) * 2004-02-23 2005-09-09 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US10413644B2 (en) 2004-04-27 2019-09-17 Smith & Nephew Plc Wound treatment apparatus and method
US8529548B2 (en) 2004-04-27 2013-09-10 Smith & Nephew Plc Wound treatment apparatus and method
US7753894B2 (en) 2004-04-27 2010-07-13 Smith & Nephew Plc Wound cleansing apparatus with stress
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
CN1950120B (zh) * 2004-05-11 2010-10-20 伟亚医疗森迪斯公司 一氧化氮气体的间歇计量
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7618594B2 (en) * 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
WO2006023616A2 (en) * 2004-08-18 2006-03-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
US8635217B2 (en) * 2004-09-15 2014-01-21 Michael J. Markus Collections of linked databases
US8412706B2 (en) 2004-09-15 2013-04-02 Within3, Inc. Social network analysis
US8577886B2 (en) * 2004-09-15 2013-11-05 Within3, Inc. Collections of linked databases
US20070260599A1 (en) * 2004-09-15 2007-11-08 Mcguire Heather A Social network analysis
US8880521B2 (en) * 2004-09-15 2014-11-04 3Degrees Llc Collections of linked databases
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
GB0505035D0 (en) * 2005-03-11 2005-04-20 Insense Ltd Improvements relating to skin dressings
FR2883165B1 (fr) * 2005-03-15 2007-05-18 Oreal Composition cosmetique anhydre contenant du monoxyde d'azote dans un materiau solide cristallin microporeux
WO2006097351A1 (en) * 2005-03-15 2006-09-21 L'oreal Anhydrous cosmetic composition comprising nitrogen monoxide in a microporous solid crystalline material
WO2006097349A1 (en) * 2005-03-15 2006-09-21 L'oreal Cosmetic use of a microporous solid crystalline material no for improving the natural colouring and/or appearance of the skin and/or lips
FR2883166B1 (fr) * 2005-03-15 2007-05-18 Oreal Composition cosmetique anhydre contenant du monoxyde d'azote dans un materiau solide cristallin microporeux
WO2006097352A1 (en) * 2005-03-15 2006-09-21 L'oreal Cosmetic composition containing nitrogen monoxide in a microporous crystalline solid material
FR2883163B1 (fr) * 2005-03-15 2007-05-18 Oreal Utilisation cosmetique d'un materiau solide cristallin microporeux contenant du no pour ameliorer l'aspect et/ou la coloration naturelle de la peau et/ou des levres
DK1871433T3 (da) 2005-03-24 2009-08-10 Nolabs Ab Kosmetisk behandling med nitrogenoxid, anordning til udförelse af denne behandling samt fremstillingsproces dertil
EP1704876A1 (de) * 2005-03-24 2006-09-27 NOLabs AB Kosmetische Behandlung, Vorrichtung zur Durchführung dieser Behandlung und deren Herstellungsmethode
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
AU2006249323B2 (en) 2005-05-27 2012-08-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
WO2007005463A2 (en) * 2005-06-29 2007-01-11 S.M.A.R.T. Link Medical, Inc. Collections of linked databases
SE529058C2 (sv) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning, användning av en plasmakirurgisk anordning och förfarande för att bilda ett plasma
SE529056C2 (sv) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning och användning av en plasmakirurgisk anordning
SE529053C2 (sv) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning och användning av en plasmakirurgisk anordning
US8190681B2 (en) * 2005-07-27 2012-05-29 Within3, Inc. Collections of linked databases and systems and methods for communicating about updates thereto
CA2619925A1 (en) 2005-09-07 2007-03-15 Tyco Healthcare Group Lp Wound dressing with vacuum reservoir
US10395326B2 (en) * 2005-11-15 2019-08-27 3Degrees Llc Collections of linked databases
WO2007057763A2 (en) * 2005-11-18 2007-05-24 Pulmonox Technologies Corporation Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
CN1990045B (zh) * 2005-12-30 2010-12-22 北京尼奥克斯生物科技有限公司 一种新型高效烧烫伤类贴剂及其制备方法
US8790715B2 (en) * 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
GB0614278D0 (en) * 2006-07-19 2006-08-30 Insense Ltd Hydrogen peroxide delivery system
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
US8079998B2 (en) * 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
WO2008079993A2 (en) * 2006-12-22 2008-07-03 Ikaria, Inc. Combinations of nitric oxide and sulfide and methods of use and manufacture thereof
US7928338B2 (en) 2007-02-02 2011-04-19 Plasma Surgical Investments Ltd. Plasma spraying device and method
US20080193385A1 (en) * 2007-02-08 2008-08-14 Todd Maibach Compositions and methods for treating neuropathy
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
EP2131903B1 (de) 2007-03-23 2018-01-24 Geno LLC Umwandlung von stickstoffdioxid (no2) in stickoxid (no)
CA2687640A1 (en) * 2007-03-27 2008-10-02 Nolabs Ab Topical dermal delivery device for nitric oxide delivery
US20100292280A1 (en) * 2007-04-15 2010-11-18 Oron Zachar Anti-pyretic vasodilators
WO2008134490A1 (en) * 2007-04-26 2008-11-06 2B Technologies, Inc Method to produce a calibration, reagent or therapeutic gas by exposing a precursor gas to ultraviolet light
US8735766B2 (en) 2007-08-06 2014-05-27 Plasma Surgical Investments Limited Cathode assembly and method for pulsed plasma generation
US7589473B2 (en) 2007-08-06 2009-09-15 Plasma Surgical Investments, Ltd. Pulsed plasma device and method for generating pulsed plasma
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US20090130233A1 (en) * 2007-10-24 2009-05-21 Baker Christopher G Two part lotion
CN101939014B (zh) * 2007-11-15 2016-04-27 路易斯安那州大学及农业和机械学院管理委员会 亚硝酸盐在慢性缺血中的应用
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
WO2009093169A1 (en) * 2008-01-22 2009-07-30 Koninklijke Philips Electronics N.V. Device for the topical delivery of nitric oxide to a skin surface
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
EP2247381B1 (de) * 2008-01-28 2016-11-30 Geno LLC Umwandlung von stickstoffdioxid (no2) in stickstoffmonoxid (no)
US8720436B2 (en) * 2008-01-31 2014-05-13 Genosys, Inc. Nitric oxide gel apparatus and method
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
US20110104240A1 (en) * 2008-06-24 2011-05-05 Micropharma Limited Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
CA2737461A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
US8613958B2 (en) 2009-06-22 2013-12-24 Geno Llc Nitric oxide therapies
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
RU2505291C2 (ru) 2009-06-24 2014-01-27 СТРАТЕДЖИК САЙЕНС ЭНД ТЕКНОЛОДЖИЗ, ЭлЭлСи Топическая композиция, содержащая ибупрофен
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
EP2724739B1 (de) 2009-07-30 2015-07-01 Tandem Diabetes Care, Inc. Tragbares Infusionspumpensystem
CA3062005C (en) 2009-08-21 2022-02-15 Novan, Inc. Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
CA2781295C (en) * 2009-11-20 2018-02-13 Geno Llc Nitric oxide delivery system
WO2011085484A1 (en) * 2010-01-13 2011-07-21 Nitric Solutions Inc. Antimicrobial nitric oxide compositions
US8613742B2 (en) 2010-01-29 2013-12-24 Plasma Surgical Investments Limited Methods of sealing vessels using plasma
US9089319B2 (en) 2010-07-22 2015-07-28 Plasma Surgical Investments Limited Volumetrically oscillating plasma flows
US20120107423A1 (en) 2010-11-01 2012-05-03 Ino Therapeutics Llc Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
ES2811515T3 (es) 2010-12-29 2021-03-12 Strategic Science & Tech Llc Tratamiento de disfunción eréctil y otras indicaciones
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof
EP2729131B1 (de) 2011-07-05 2020-04-15 Novan, Inc. Topische zusammensetzungen
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
WO2013085784A1 (en) * 2011-12-05 2013-06-13 Nioxx Llc Compositions and methods for topical nitric oxide generation
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
NZ701832A (en) 2012-05-23 2016-08-26 Cellix Bio Private Ltd Compositions and methods for treatment of inflammatory bowel disease
JP2015518854A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 多発性硬化症の治療のための組成物および方法
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
CN103622917B (zh) * 2012-08-23 2017-12-29 尼奥克斯(文莱)控股有限公司 基于微囊化亚硝酸盐和酸化水凝胶的延时产生一氧化氮的系统和方法
US20140065090A1 (en) * 2012-08-31 2014-03-06 W. L. Gore & Associates, Inc. Reactive Oxidative Species Generating Materials and Methods of Use
US9259435B2 (en) 2012-08-31 2016-02-16 W. L. Gore & Associates, Inc. Reactive oxidative species generating materials and methods of use
US8871258B2 (en) * 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US9724419B2 (en) * 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US20140271937A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314422B2 (en) * 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9750787B2 (en) * 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
EP3030266B1 (de) 2013-08-08 2020-10-28 Novan Inc. Topische zusammensetzungen und verfahren zur verwendung davon
WO2016128991A1 (en) 2015-02-09 2016-08-18 Cellix Bio Private Limited Compositions and methods for the treatment of mucositis
CN106456666A (zh) 2014-01-10 2017-02-22 Ino治疗有限责任公司 使用吸入性一氧化氮气体来治疗儿童的急性呼吸窘迫综合征的方法
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
US10322081B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
EP3177262A4 (de) 2014-08-08 2018-04-18 Novan Inc. Topische emulsionen
AR101582A1 (es) * 2014-08-18 2016-12-28 Bovicor Pharmatech Inc Tratamiento de tejido mamario con óxido nítrico
SG11201706952VA (en) 2014-09-26 2017-10-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy and neurological disorders
EP3201168B1 (de) 2014-09-29 2020-03-18 Cellix Bio Private Limited Verbindungen und zusammensetzungen zur behandlung multipler sklerose
AU2014414316B2 (en) 2014-10-27 2020-04-09 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
WO2016067297A1 (en) 2014-10-27 2016-05-06 Cellix Bio Private Limited Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
WO2016077386A1 (en) * 2014-11-10 2016-05-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Topical sodium nitrite formulation
WO2016088132A1 (en) 2014-12-01 2016-06-09 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
ITUB20154719A1 (it) * 2015-10-21 2017-04-21 Glano Tech Ltd Formulazione per il rilascio di ossido nitrico
WO2017132275A1 (en) 2016-01-27 2017-08-03 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
EP3423100A4 (de) 2016-03-02 2019-10-16 Novan, Inc. Zusammensetzungen zur behandlung von entzündungen und verfahren zur behandlung davon
WO2017180822A1 (en) 2016-04-13 2017-10-19 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
US11173235B2 (en) 2016-07-15 2021-11-16 Cook Regentec Llc Nitrite eluting devices and methods of use thereof
MX387330B (es) 2016-08-11 2025-03-18 Cellix Bio Private Ltd Composiciones y metodos para el tratamiento de sindrome de intestino irritable
WO2018065831A1 (en) 2016-10-04 2018-04-12 Cellix Bio Private Limited Compositions and methods for the treatment of xerostomia
EP3554494A4 (de) 2016-12-19 2021-02-17 Cellixbio Private Limited Zusammensetzungen und verfahren zur behandlung von entzündungen
PL3579888T3 (pl) * 2017-02-09 2024-05-27 Noxsano Inc. Kompozycje wytwarzające elektrochemiczny transmiter oraz sposoby ich stosowania oraz opatrunki i układy leczenia, w których się je stosuje
WO2019023605A1 (en) 2017-07-27 2019-01-31 Allergan, Inc. PROSTACYCLINE RECEPTOR AGONISTS FOR BODY GREASE REDUCTION
CN108096297B (zh) * 2017-10-11 2020-12-18 河北京鼎生物医药科技有限公司 包含微囊化的菠菜萃取物和酸性微囊化粉末的一氧化氮延时释放系统和成套用品
CN108096296B (zh) * 2017-10-11 2020-10-16 河北京鼎生物医药科技有限公司 基于菠菜萃取物的微胶囊化粉末和酸性凝胶延长产生一氧化氮的系统和用品
KR102003876B1 (ko) * 2017-11-01 2019-10-04 경희대학교 산학협력단 에멀젼 타입의 유중수형 발기부전 개선용 조성물
AU2018367909B2 (en) 2017-11-17 2022-03-10 Cellix Bio Private Limited Compositions and methods for the treatment of eye disorders
KR102405239B1 (ko) 2017-11-17 2022-06-08 셀릭스 바이오 프라이빗 리미티드 눈 질환 및 피부 질환의 치료를 위한 화합물, 조성물 및 방법
WO2019114705A1 (zh) 2017-12-13 2019-06-20 上海小午医药科技有限公司 一种用于预防或治疗与egfr被抑制相关疾病的方法
WO2019175674A2 (en) 2018-03-13 2019-09-19 Regev Gilly Nitric oxide releasing compositions
US10716805B2 (en) * 2018-03-19 2020-07-21 Glanotech Limited Formulation for release of nitric oxide
CN111989095A (zh) 2018-04-16 2020-11-24 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法
WO2020227367A1 (en) * 2019-05-06 2020-11-12 Pneuma Nitric Oxide, Llc Nitric oxide compositions and topical uses thereof
GB2599576B (en) 2019-06-04 2023-09-13 Thirty Holdings Ltd Methods and compositions for generating nitric oxide and uses thereof
EP3980032A1 (de) 2019-06-04 2022-04-13 Thirty Respiratory Limited Verfahren und zusammensetzungen zur erzeugung von stickoxid und verwendungen davon zur abgabe von stickoxid über die atemwege
US20210052842A1 (en) * 2019-08-23 2021-02-25 NOTA Laboratories, LLC Nitric oxide generating systems for nasal inhalation
EP4233830A3 (de) 2019-10-07 2023-09-20 Insense Limited Zusammensetzung zur abgabe von stickstoffoxid an die haut
EP4138795A1 (de) 2020-04-23 2023-03-01 Thirty Respiratory Limited Stickoxid oder stickoxid freisetzende zusammensetzungen zur verwendung bei der behandlung von sars-cov und sars-cov-2
GB2610721B (en) 2020-04-23 2024-07-31 Thirty Respiratory Ltd Compositions for treating and combatting tuberculosis
US12459820B2 (en) 2020-06-11 2025-11-04 J. W. Randolph Miller Stabilized and NO2-inhibited nitric oxide generating gels for inhaled nitric oxide therapy
CA3191050A1 (en) 2020-08-28 2022-03-03 Nikolay Suslov Systems, methods, and devices for generating predominantly radially expanded plasma flow
GB2644374A (en) * 2024-09-20 2026-04-08 Thirty Holdings Ltd Compositions and kits for generating nitric oxide

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2054661A1 (en) * 1970-11-06 1972-05-10 Badische Anilin & Soda Fabrik AG, 6700 Ludwigshafen N-nitrosa-n-aryl-hydroxylamines prepn - from nitrosa-arenes and nitrogen oxide
GB1322812A (en) * 1971-02-04 1973-07-11 Ilford Ltd Photographic materials
US4535154A (en) * 1981-07-13 1985-08-13 United States Of America Reductive destruction of nitrosamines, hydrazines, nitramines, azo- and azoxy-compounds
US4954526A (en) * 1989-02-28 1990-09-04 The United States Of America As Represented By The Department Of Health And Human Services Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5039705A (en) * 1989-09-15 1991-08-13 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5212204A (en) * 1989-10-18 1993-05-18 The United States Of America As Represented By The Department Of Health And Human Services Antihypertensive compositions and use thereof
US5155137A (en) * 1990-09-20 1992-10-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complexes of nitric oxide with polyamines
US5683668A (en) * 1990-09-20 1997-11-04 The United States Of America As Represented By The Department Of Health And Human Services Method of generating nitric oxide gas using nitric oxide complexes
US5185376A (en) * 1991-09-24 1993-02-09 The United States Of America As Represented By The Department Of Health And Human Services Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof
JP3746293B2 (ja) * 1993-02-22 2006-02-15 アメリカン バイオサイエンス、インコーポレイテッド 生物製剤のインビボ送達の方法とそのための組成物
US5840759A (en) * 1993-10-08 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
JPH09508097A (ja) * 1993-11-02 1997-08-19 アメリカ合衆国 虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
US5698738A (en) * 1995-05-15 1997-12-16 Board Of Regents, The University Of Texas System N-nitroso-N-substituted hydroxylamines as nitric oxide donors
US5726209A (en) * 1995-06-07 1998-03-10 Alliance Pharmaceutical Corp. Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
SE9700617D0 (sv) * 1997-02-21 1997-02-21 Kjell Alving New composition
US5888528A (en) * 1997-05-19 1999-03-30 Bernard Technologies, Inc. Sustained release biocidal powders
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide

Also Published As

Publication number Publication date
CA2410990C (en) 2011-08-02
AU2000250426B2 (en) 2005-06-30
EP1283724B1 (de) 2009-05-06
US6103275A (en) 2000-08-15
WO2001089572A1 (en) 2001-11-29
DE60042174D1 (de) 2009-06-18
AU5042600A (en) 2001-12-03
AU2000250426A1 (en) 2002-02-21
US7048951B1 (en) 2006-05-23
CA2410990A1 (en) 2001-11-29
EP1283724A1 (de) 2003-02-19

Similar Documents

Publication Publication Date Title
DE60042174D1 (de) Systeme und verfahren zur topischen behandlung mit stickstoffmonoxyd
EP0679390A3 (de) Aufsprühbare pharmazeutische Zubereitungen für die topische Anwendung
AU3694901A (en) A parasiticidal formulation and a method of making this formulation
ES459938A1 (es) Procedimiento para obtener una composicion farmaceutica en forma de un gel de polimero carboxivinilico, para insercion en el cuerpo
KR950703972A (ko) 항혈전성 치료 및 암 예방을 위한 아세틸살리실산을 함유하는 경피 투여 시스템(transdermal administration system containing acetylsalicyliic acid for antithrombotic therapy and the prevention of cancer)
ZA947338B (en) Use of angiotensin II and analogs thereof in tissue repair
JP2003501208A5 (de)
CA2326662A1 (en) Therapeutic system which can be moisture-activated
AU5792399A (en) Stable ascorbic acid preparation for topical use
DK163911C (da) Indomethacinholdig gelagtig salve
US4781923A (en) Antiseptic gels
ATE92303T1 (de) Periodontische zusammensetzung und verfahren.
TR199801104T2 (xx) Ereksiyon disfonksiyonunun tedavisinde kullan�lan PGE-1 i�eren liyofilize lipozomlar.
AU2001272452A1 (en) Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
WO1999044573B1 (en) Composition and means for treating dry mouth
JPS57167919A (en) Preventing agent for intraperitoneal adhesion
ATE245443T1 (de) Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer
US4191748A (en) Novel medicinal composition, especially for the treatment of cellulitis
ZA988820B (en) Use of delta-aminolaevulinic acid for the preparation of a topical medicament for the integral diagnosis and/or therapy of tumours in hollow organs
ATE294568T1 (de) Zusammensetzung zur behandlung von verbrennungen
BR9608721A (pt) Composição farmacêutica, e, processo para tratar inflamação
WO2003080110A8 (es) Liquido topico destructor de tejido patogeno
WO2001010431A3 (en) Headache and colic relief composition with asafetida and method of use thereof
RU94002975A (ru) Препарат для массажа "малавит"

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties